InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Keros Therapeutics, Inc.

KROS Clue Score73
United States Fiscal year ends December CIK 0001664710 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

5
Insider
Date
Role
Action
Shares
Price
Amount
Charles W. Newton
18 Aug 2026
Director
Sold on a plan
551
$10.30
$5.68K
Charles W. Newton
11 Jun 2026
Director
Sold on a plan
550
$10.04
$5.52K
Alpna Seth
4 Jun 2026
Director
Sold on a plan
2,625
$10.72
$28.14K
Julius Knowles
4 Jun 2026
Director
Sold on a plan
2,625
$10.73
$28.17K
Nima Farzan
4 Jun 2026
Director
Sold on a plan
2,625
$10.73
$28.17K
Showing 250 of 403 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 174
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 14
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 72
Sales at will 274
Transactions with no price 0
Shares from compensation/vesting 18,653,788
Sales filed before the plan box existed 256
History held since 8 Apr 2020